NeuroDevNet researchers have made the first steps towards identifying an epigenetic signature for Fetal Alcohol Spectrum Disorder (FASD), drawing from the largest-ever study of children and youth exposed to alcohol before birth.
The multi-disciplinary group found a diverse pattern of DNA methylation that possibly indicates modified genetic expression in 110 children diagnosed with FASD, or known to have a history of prenatal alcohol exposure, compared to 96 age- and sex-matched controls aged 5-18.
NeuroDevNet welcomes Dr. Sheila Laredo as our new Chair of the Board of Directors.
Upon joining the board in 2013, Dr. Laredo brought a wealth of experience as a clinician with a primary interest in women’s reproductive health, and immersion in neurodevelopmental issues as a seasoned advocate and parent of two children on the autism spectrum.
Findings emerging from ongoing work by Autism Research Group Co-Lead Dr. Stephen Scherer, colleague Dr. Ryan Yuen, and collaborators indicate that clusters of de novo, or new mutations in the genome of mothers likely to contribute to autism.
“Genome-wide characteristics of de novo mutations in autism,” published August 3 in npj |Genomic Medicine is the largest-yet whole genome study of autism, involving data from 200 children and their unaffected parents.
Newly-minted NeuroDevNet post-doc Dr. Veronica Schiariti is traveling the globe from Stockholm to Xian, where researchers and clinicians are keen to consult her expertise in applying a functional, ability-oriented lens to assessment and treatment of children and youth with cerebral palsy (CP).
A pediatrician before she pursued further training in developmental neurosciences and child health at the University of British Columbia, Schiariti has developed clinical tools based on the World Health Organization’s Pediatric International Classification of Functioning, Disability and Health (ICF).